In response to an announcement of a series of leadership and business changes, shares of MiMedx Group (NASDAQ: MDXG), a beaten-down biopharmaceutical company that is focused on regenerative medicine, fell 31% as of 10:25 a.m. EDT Monday.Here's an overview of the changes that were announced today:Image source: Getty Images.Continue reading